VERILOID Drug Patent Profile
When do Veriloid patents expire, and what generic alternatives are available?
Veriloid is a drug marketed by 3M and is included in one NDA.
The generic ingredient in VERILOID is alkavervir. There is one drug master file entry for this compound. Additional details are available on the alkavervir profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VERILOID?
- What are the global sales for VERILOID?
- What is Average Wholesale Price for VERILOID?
Summary for VERILOID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| DailyMed Link: | VERILOID at DailyMed |
US Patents and Regulatory Information for VERILOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | VERILOID | alkavervir | TABLET;ORAL | 007336-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| 3m | VERILOID | alkavervir | TABLET;ORAL | 007336-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
VERILOID Market Dynamics and Financial Trajectory: Sales Drivers, Competitive Pressure, and Exclusivity/Litigation Watchpoints
More… ↓
